CSSI PROFILE

          

OUR NEW PROFILE IS:    (OTC: CSSI)

_______________

CSSI Completes Acquisition of Florida Based, Prime Dental Lab, LLC

Costas Reports 2022 3rd Quarter Revenue and Exit from Shell Status

The acquisition of Prime Dental delivers more than ten years of experience and 2021 unaudited gross revenue in excess of $600,000.

______________________________

Hello Everyone,

The market just opened seconds ago and we have CSSI on our radar for today.  

This one is extremely thin and has a very limited history so make sure you are watching it very close this morning.

It is a company that you want to get on you’re radar right now as things look like they are still in it’s infancy but progressing forward as you follow the press releases below.

CSSI has developed branding and a detailed business plan to facilitate the acquisition of small to medium sized dental labs, of which there are thousands in the United States. Similar models have been extensively used in the medical clinic and dental clinic industries over the past 30 years, but dental laboratories remain highly fragmented. “Consolidating small, privately owned labs into larger, regionally managed facilities will bring economies of scale, and enhance competitiveness and product quality in regional markets.” said Costas CEO, James Brooks.

SDL has been actively looking for dental lab owners interested in selling their labs over the recent months. With the recently acquired consolidation model and ready to launch branding, the Company expects to identify several suitable acquisition targets in the coming weeks and months, with the goal of becoming one of the largest operators in the industry. “There’s no faster way to grow than through acquisition, and this industry, in particular, remains unsophisticated in the public sector.”, added Brooks.

Consolidation of this industry, currently represented by 7,000+ privately owned businesses, is now the Company’s focus. The acquired business model will allow the Company to quickly identify suitable targets, to build and scale in order to become regionally competitive. In the process, the Company will be positioning itself as a leader in setting new standards for the dental lab industry.

Acquiring cash flowing, and profitable businesses with a financial track record, is Standard Dental Labs business strategy. The dental lab industry as a whole is estimated to be a $10B market in the US alone in 2022 (source: Grandview Research, Aug. 2021), but is growing steadily.

As you read the press releases below you will see the progression of the business plan start to unfold from the acquisition of a company, to their first revenue generating acquisition to removal of shell status and a planned uplisting to a higher quality exchange.

Costas, Inc. Closes Agreement To Acquire Assets of Standard Dental Labs Inc

ORLANDO, FL / ACCESSWIRE / May 6, 2022 / Costas, Inc. (OTCMKTS:CSSI), Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI):

COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. As previously announced, on February 28th, 2022, the shareholders of Standard Dental Labs Inc. (“SDL”) voted unanimously in favor of accepting an offer from CSSI to acquire its assets. The Company is pleased to announce the parties have entered into a formal acquisition agreement, which is expected to close in the coming days. The completion of this acquisition will cement the Company’s entry into the dental lab industry, paving the way for future acquisitions and consolidations in the industry.

The business model acquired from SDL, a company incorporated in Wyoming in 2019, and controlled by Mr. Brooks, the Company’s CEO, has developed branding and a detailed business plan to facilitate the acquisition of small to medium sized dental labs, of which there are thousands in the United States. Similar models have been extensively used in the medical clinic and dental clinic industries over the past 30 years, but dental laboratories remain highly fragmented. “Consolidating small, privately owned labs into larger, regionally managed facilities will bring economies of scale, and enhance competitiveness and product quality in regional markets.” said Costas CEO, James Brooks.

SDL has been actively looking for dental lab owners interested in selling their labs over the recent months. With the recently acquired consolidation model and ready to launch branding, the Company expects to identify several suitable acquisition targets in the coming weeks and months, with the goal of becoming one of the largest operators in the industry. “There’s no faster way to grow than through acquisition, and this industry, in particular, remains unsophisticated in the public sector.”, added Brooks.

Costas, Inc. Completes Acquisition of Florida Based Dental Lab, Prime Dental Lab, LLC

ORLANDO, FL / ACCESSWIRE / August 16, 2022 / Costas, Inc. (OTC PINK:CSSI), Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI):

COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. The Board of Directors of CSSI is pleased to announce the completion of a definitive agreement to acquire Prime Dental Lab, LLC. (“Prime Dental”), an Orlando-based dental lab in operation since 2012, under the ownership and management of Mr. John Kim. The acquisition of Prime Dental delivers more than ten years of experience and 2021 unaudited gross revenue in excess of $600,000.

The opportunity to acquire Prime Dental follows the May 6, 2022, acquisition of certain assets of Standard Dental Labs Inc. (“SDL”), a company founded by CSSI CEO, James Brooks. Now operating under the DBA SDL, CSSI is currently searching for dental lab owners that have struggled to find an exit from the industry, intending to retire or who lack the resources to remain competitive. Among the assets acquired from SDL was the comprehensive business plan and roll up strategy aimed to facilitate the acquisition of these small to medium-sized dental labs, of which there are thousands in the United States.

On August 15, 2022, following a due diligence process, CSSI and Prime Dental executed an Asset Purchase Agreement. Total consideration of $700,000.00 will be paid to the shareholders of Prime Dental in a combination of cash and registered shares for the assets, which includes all equipment, the client base, and associated revenue. Shares will be escrowed over two years, paid in quarterly installments. Although both parties have executed the agreement, it will not be ratified until the submission of a Form S-1 Registration with the Securities and Exchange Commission and receipt of notice of effect.

The acquisition of Prime Dental is the latest in a series of dental labs the Company plans to acquire in the coming years. CSSI’s mandate is to acquire cash-flowing, profitable businesses with strong financial track records and consolidate these operations, achieving operational efficiencies and enhancing the bottom line. Prime Dental brings immediate revenue-generating operations, and CSSI plans to facilitate access to previously inaccessible cutting-edge equipment, kickstarting growth.

In 2022, the dental lab industry is estimated to be a $10B market in the US (source: Grandview Research, Aug. 2021) and continues to grow. Therefore, consolidation within the industry, represented by 7,000+ privately owned businesses, is the Company’s focus. In the process, Costas Inc. will be positioning itself as a leader in setting new standards for the dental lab industry. It expects to continue identifying suitable acquisitions in the coming weeks and months, focusing on becoming one of the largest operators in the industry.

Costas Reports 2022 3rd Quarter Revenue and Exit from Shell Status

ORLANDO, FL / ACCESSWIRE / November 30, 2022 / Costas, Inc. (OTC PINK:CSSI) (“CSSI” or “the Company”), doing business as Standard Dental Labs Inc., reports that it has recorded 3rd quarter gross revenues of $44,770 in its most recent quarterly financial report. The third quarter revenues are the result of the recent acquisition of operating assets, including customer contracts and lab equipment, from Prime Dental Labs with an effective date of September 1, 2022. The reported revenues are the Company’s first recorded revenues under new management from planned dental lab acquisitions and operations.

Now that Standard Dental Labs expects to report ongoing monthly revenue, the Company has also filed a supplemental notice to shareholders notifying them that the Company is no longer a “Shell Company”, as defined under Rule 405 of the US Securities Act of 1933 (“Rule 405”). The removal of the “Shell” symbol on the OTCMarkets landing page, once removed by OTCMarkets, will be a significant milestone for Costas, Inc., and evidence of the Company’s continuing effort to improve corporate governance and disclosure compliance for shareholders. The determination to remove Shell status is at the sole discretion of OTCMarkets, and is not an indicator of any compliance issues.

The Company will continue to make efforts to acquire more dental labs in the Orlando, Florida region, with the goal of consolidating those labs into one, larger location where we will be able to capitalize on the economies of scale and joint experience.

In 2022, the dental lab industry is estimated to be a $10B market in the US (source: Grand View Research, Aug. 2021) and continues to grow. Therefore, consolidation within the industry, represented by 7,000+ privately owned businesses, is the Company’s focus. In the process, the Company will be positioning itself as a leader in setting new standards for the dental lab industry. It expects to continue identifying suitable acquisitions in the coming weeks and months, focusing on becoming one of the largest operators in the industry.

Costas, Inc. Engages Independent Registered Public Accounting Firm, Progressing Corporate Roadmap

ORLANDO, FL / ACCESSWIRE / August 24, 2022 / Costas, Inc. (OTC PINK:CSSI), Costas, Inc. (“CSSI” or “the Company”). About COSTAS (CSSI):

COSTAS, INC. is a publicly traded company listed on OTCMarkets under the trading symbol ‘CSSI’. The Company is pleased to report that it has recently engaged an Independent Registered Public Accounting Firm to audit the financial results for Costas, Inc. (OTCMKTS: CSSI) and Prime Dental Lab LLC. for the most recent two fiscal years ended December 31, 2021 and 2020, and the six-month comparative interim periods ended June 30, 2022 and 2021. As previously announced, on August 15, 2022, Costas entered into an agreement to purchase the assets of Prime Dental Lab LLC, including its client base and revenue (the “Asset Purchase Agreement”).

The Independent PCAOB Registered Public Accounting Firm will audit both companies according to US GAAP; including a review of revenue recognition policies in accordance with ASC 606.

The objective for Costas is to become a fully reporting issuer with a class of securities registered with the Securities and Exchange Commission (“SEC”), while substantially growing revenue generating operations via the acquisition of central labs with existing manufacturing capabilities. The Company expects to complete the audits and file a Form S-1 Registration with the SEC. Within the next few months, CSSI hopes to be listed on the OTCQB and maintain business as a fully reporting issuer.

GET NOTIFIED
I agree to have my personal information transfered to iContact ( more information )
Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
content-main